RecruitingPhase 1NCT06904066
Blood
Precursor T-cell acute lymphoblastic leukemia
151
studies recruiting now
as of 7 Sept 2026
1,023
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
1 Apr 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT05621291
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
RecruitingPhase 2NCT06514794
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 1NCT06408194
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
RecruitingPhase 1NCT04881240
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 151 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Precursor T-cell acute lymphoblastic leukemia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Precursor T-cell acute lymphoblastic leukemia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (ABL1, SET, NUP214, ZBTB16, SALL2, TRA).
Treatments being studied
1 approved treatment and 1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Nelarabine (Arranon)
Phase 2Isatuximab (Sarclisa)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).